SUSMED Competitors and Similar CompaniesClear all
CEL-SCI's competitors and similar companies include Upstream Bio.
 CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases. |  Upstream Bio Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases. | |
Founding Date | Founding Date 1983 | Founding Date 2021 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Vienna, US HQ | Locations Waltham, US HQ |
Employees | Employees N/A | Employees 38 |
Valuation ($) | Valuation ($) 58.7 m | Valuation ($) 1.3 b |
Financial | ||
Net income | Net income ($25.4m) (FY, 2025) | Net income ($143.4m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Upstream Bio
HQ
Waltham, US
Employees
38
Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases.
View company